ArticleRheumatology and immunology research2021

Tocilizumab for Severe COVID-19 Pneumonia: Experience from 5 Geriatric Chinese Patients with 6 Months Follow-up.

Aihua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.